Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2007

01-09-2007

Pattern of workplace disputes in cancer survivors: a population study of ADA claims

Authors: Michael Feuerstein, Gina M. Luff, Cherise B. Harrington, Cara H. Olsen

Published in: Journal of Cancer Survivorship | Issue 3/2007

Login to get access

Abstract

Background

The Americans with Disability Act (ADA) claim patterns can provide information on sources of potential work discrimination faced by employees with various health problems. This study investigated the pattern of ADA disputes among cancer survivors and non-cancer related impairments.

Materials and methods

Using multivariable logistic regression adjusting for demographics, employees with cancer related claims were compared to employees with other impairment related claims for alleged violations from 2000 to 2005. The impairments were grouped into orthopedic, behavioral, medical, neurologica1, sensory, cancer, cancer comorbid (cancer and non-cancer impairments), and comorbid “other” (non-cancer comorbid disorders). The dispute categories included: termination, reasonable accommodation, relations, terms, hiring, and a nonspecific “other” category.

Results

This study analyzed 59,981 cases over a 6 year period. All comparisons were made in relation to the cancer group. There was a protective effect for any impairment other than cancer (OR = 0.29–0.63, 95% CI = 0.25–0.72) related to discharge from work. Also, orthopedic (OR = 0.81, 95% CI = 0.71–0.93), general medical (OR = 0.82, 95% CI = 0.72–0.94), and neurological (OR = 0.83, 95% CI = 0.71–0.96) impairments were found to be protective for claims related to terms of employment relative to cancer. Cancer survivors who reported a second impairment in addition to cancer were more likely to file disputes that involved relations with others at work (OR = 1.47, 95% CI = 1.16–1.87) in comparison to those with cancer only. Orthopedic (OR = 2.42, 95% CI = 2.13–2.76), neurological (OR = 1.50, 95% CI = 1.30–1.72), and sensory (OR = 1.50, 95% CI = 1.29–1.73) groups were more likely to file accommodation related disputes than the cancer group. Sensory (OR = 4.41, 95% CI = 3.45–5.63), other-comorbid (OR = 2.33, 95% CI = 1.85–2.94), medical (OR = 1.92, 95% CI = 1.51–2.44), and neurological (OR = 1.59, 95% CI = 1.23–2.05) impairment groups filed more disputes related to hiring than the cancer or the cancer-comorbid group.

Conclusion

Cancer survivors are more likely to file job loss claims and differential treatment related to workplace policies. Those with cancer and another impairment file more claims related to relationship problems at work than cancer only. The factors accounting for these claims need to be explored in future research in order to develop more specific evidence based policy and practice.

Implications for cancer survivors

While the percentage of cancer survivors who file claims are relatively small, job termination and terms of employment are more likely to be concerns for cancer survivors than employees with other types of impairments. If a cancer survivor has another health problem as well relationship disputes are likely to emerge.
Literature
2.
3.
go back to reference Bouknight R, Bradley C, Zhehui L. Correlates of return to work for breast cancer survivors. JCO. 2006;2:345–53.CrossRef Bouknight R, Bradley C, Zhehui L. Correlates of return to work for breast cancer survivors. JCO. 2006;2:345–53.CrossRef
4.
go back to reference Schultz P, Beck M, Stava C, Sellin R. Cancer survivors: work related issues. American Association of Occupational Health Nurses. 2002;50:220–26. Schultz P, Beck M, Stava C, Sellin R. Cancer survivors: work related issues. American Association of Occupational Health Nurses. 2002;50:220–26.
6.
go back to reference Lerner D, Allaire S, Reisine S. Work disability resulting from chronic health conditions. J Occup Environ Med. 2005;47:253–64.PubMedCrossRef Lerner D, Allaire S, Reisine S. Work disability resulting from chronic health conditions. J Occup Environ Med. 2005;47:253–64.PubMedCrossRef
8.
go back to reference CFR. Code of Federal Regulation (Section 1630.2). Beltsville, MD: CFR; 1990. CFR. Code of Federal Regulation (Section 1630.2). Beltsville, MD: CFR; 1990.
9.
go back to reference Main D, Nowels C, Cavender T, Etschmaier M, Steiner J. A qualitative study of work and work return in cancer survivors. Psycho Oncol. 2005;4:992–1004.CrossRef Main D, Nowels C, Cavender T, Etschmaier M, Steiner J. A qualitative study of work and work return in cancer survivors. Psycho Oncol. 2005;4:992–1004.CrossRef
10.
go back to reference Huang G, Feuerstein M. Americans with disabilities act litigation and musculoskeletal-related impairments: implications for work re-entry. J Occup Rehabil. 1998;8:91–102.CrossRef Huang G, Feuerstein M. Americans with disabilities act litigation and musculoskeletal-related impairments: implications for work re-entry. J Occup Rehabil. 1998;8:91–102.CrossRef
11.
go back to reference McKenna M, McMahon B, Fabian E, Hurley J. Workplace discrimination and cancer. Work. 2007, (in press). McKenna M, McMahon B, Fabian E, Hurley J. Workplace discrimination and cancer. Work. 2007, (in press).
12.
go back to reference Bradley C, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Investig. 2007;25:47–54.CrossRef Bradley C, Neumark D, Luo Z, Schenk M. Employment and cancer: findings from a longitudinal study of breast and prostate cancer survivors. Cancer Investig. 2007;25:47–54.CrossRef
13.
go back to reference Short P, Vasey J, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–1301.PubMedCrossRef Short P, Vasey J, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–1301.PubMedCrossRef
Metadata
Title
Pattern of workplace disputes in cancer survivors: a population study of ADA claims
Authors
Michael Feuerstein
Gina M. Luff
Cherise B. Harrington
Cara H. Olsen
Publication date
01-09-2007
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2007
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-007-0027-9

Other articles of this Issue 3/2007

Journal of Cancer Survivorship 3/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine